Auteurs
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Jeroen P. Jansen »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jeremy Abramson < Jeroen P. Jansen < Jerome Gillard  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000B93 (2017) Jeroen P. Jansen [États-Unis] ; Devin Incerti [États-Unis] ; Alex Mutebi [États-Unis] ; Desi Peneva [États-Unis] ; Joanna P. Macewan [États-Unis] ; Bradley Stolshek [États-Unis] ; Primal Kaur [États-Unis] ; Mahdi Gharaibeh [États-Unis] ; Vibeke Strand [États-Unis]Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators.
000C87 (2016) Maria-Cecilia Vieira [États-Unis] ; Samuel H. Zwillich [États-Unis] ; Jeroen P. Jansen [États-Unis] ; Brielan Smiechowski [États-Unis] ; Dean Spurden [Royaume-Uni] ; Gene V. Wallenstein [États-Unis]Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.
001166 (2015) Felicity Buckley ; Axel Finckh ; Tom W J. Huizinga ; Fred Dejonckheere ; Jeroen P. JansenComparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.
001393 (2014) Jeroen P. Jansen ; Felicity Buckley [États-Unis] ; Fred Dejonckheere ; Sarika OgaleComparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
001A20 (2010) Gert J D. Bergman [Pays-Bas] ; Marc C. Hochberg ; Maarten Boers ; Neil Wintfeld ; Adrian Kielhorn ; Jeroen P. JansenIndirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.
001D04 (????) Eric Druyts [Canada] ; Jacqueline B. Palmer [États-Unis] ; Chakrapani Balijepalli [Canada] ; Keith Chan [Canada] ; Mir Sohail Fazeli [Canada] ; Vivian Herrera [États-Unis] ; Jeroen P. Jansen [Canada] ; Jay J H. Park [Canada] ; Steve Kanters [Canada] ; Andreas Reimold [États-Unis]Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Jeroen P. Jansen" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Jeroen P. Jansen" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Jeroen P. Jansen
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021